(1)
Omalizumab Dose Step-Up and Treatment Response in Patients With Chronic Idiopathic Spontaneous Urticaria (CIU CSU): Results from the OPTIMA Study. J of Skin 2018, 2 (S1), S52. https://doi.org/10.25251/skin.2.supp.52.